ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Medical Devices Advanced Regulatory Affairs Training Course | Practical MDR Life Cycle Management Skills for Successful Product Transition (ONLINE EVENT: October 2-3, 2025) - ResearchAndMarkets.com

The "Advanced Regulatory Affairs for Medical Devices Training Course" training has been added to ResearchAndMarkets.com's offering.

Explore the MDR's updates enhancing patient safety and understand its revised requirements and processes to navigate the evolving regulatory environment effectively.

This course is crucial for professionals already versed in medical device regulatory affairs, offering indispensable guidance on transitioning products from the current Medical Device Directive (MDD) framework to the new Medical Device Regulation (MDR).

Emphasizing regulatory strategy and lifecycle management, the program includes in-depth sessions on regulatory pathways, technical documentation, clinical evaluations, and investigations. Participants will also delve into requirements for the vigilance system, post-market surveillance (PMS), and post-market clinical follow-up (PMCF) studies.

Through interactive case studies and practical workshops, delegates will solidify their knowledge and engage in discussions with two experienced medical device experts, navigating the complexities of regulatory compliance effectively.

Certifications:

  • CPD: 12 hours for your records
  • Certificate of completion

Who Should Attend:

This course will provide experienced medical device professionals with the practical regulatory knowledge to apply life cycle management in an MDR environment, particularly those who play a key role in transitioning their products to the MDR, including:

  • Medical device regulatory affairs professionals
  • Vigilance and PMS managers
  • Clinical evaluation/investigation specialists
  • Project managers

Key Topics Covered:

Day 1

The impact of the MDR on your role and responsibility

  • Why a change in regulation?
  • Structure of the new regulation and flow of compliance
  • Key analysis of the changes
  • Changes to roles and responsibilities of key stakeholders
  • Competent authorities and Notified Bodies
  • Economic operators - role and responsibilities
  • Person responsible for regulatory compliance

Borderlines and classification

  • Borderline determination
  • Software qualification and classification
  • Understanding the classification process
  • Investigating the classification rules (emphasis on the new rules)

Classification workshop: Practical session on applying the new rules

GSPRs Annex I requirements

Requirements for clinical evaluations and investigations

  • Requirements, standards and guidance
  • Understanding the importance of clinical evaluation
  • Key requirements of clinical investigations

Clinical evaluation and investigation workshop: Consolidating the key requirements

Conformity assessment

  • Various conformity assessment routes
  • Scrutiny process and key considerations
  • Selection of and engagement with your Notified Body

Day 2

The new market surveillance tools

  • The European database (EUDAMED)
  • Unique device identification (UDI)
  • Supply chain surveillance and traceability

Requirements for PMS

  • Understanding PMS requirements
  • Implementing effective PMS

The new vigilance system

  • Management of adverse incidents
  • Definitions: what is reportable, the reporting process and investigation
  • Corrective action
  • Periodic safety update reports - how to manage this requirement

Vigilance workshop: Report or not to report?

PMCF studies

  • Requirements for PMCF
  • Types of PMCF

Future Evolution of the Medical Device Legislation

  • UKCA Marking

Speakers:

Theresa Jeary

Technical Manager for Medical Devices

Lloyds Register Quality Assurance (LRQA)

Theresa Jeary holds a Master's Degree in Pharmaceutical Science and is eligible to be a Pharmaceutical Qualified Person.

Theresa has over 25 years' experience working in both the Pharmaceutical and Medical Device industries and has worked in a variety of roles across the full development cycle from product concept and early stage development, process transfer, validation and regulatory departments, and has been a part of the team for many commercially available medicinal and medical device products.

Her first introduction to the Medical device Industry was as the R&D Manager for a medical device manufacturer, with responsibility for the development of several device drug combination products, with the core technology utilizing bovine collagen.

Having been impressed by the innovative nature and speed of development in the Medical Device Industry, Theresa then pursued a move to the other side of the "fence" and into the Notified Body world of Conformity Assessment. First, at BSI as a Certification Manager in the General Device group, and now with Lloyds Register Quality Assurance (LRQA).

Over the years, Theresa has conducted many successful consultations with a large number of the European Competent Authorities as well as the European Medicines Agency (EMA) as well as reviewing the classification of borderline products.

At LRQA, Theresa is the Technical Manager for Medical Devices with responsibility for Devices Drug products and Class III Medical Device Conformity Assessments for a wide range of medical devices including In-Vitro Fertilization Media and Solutions for Organ Preservation.

For more information about this training visit https://www.researchandmarkets.com/r/i7apmu

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com



For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.